CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Other events
- 4 Open-market sale President and COO sold 1,292 shares at $276.26 ($356,927)
- 4 Open-market sale Chief Executive Officer sold 3,410 shares at an average $273.78 ($933,592)
- 4 Open-market sale President, Global Head of R&D sold 1,068 shares at $276.74 ($295,553)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale President and COO sold 1,357 shares at $266.76 ($361,997)
- 4 Open-market sale Chief Executive Officer sold 3,693 shares at an average $265.55 ($980,686)
- 4 Open-market sale SVP, General Counsel sold 590 shares at $265.98 ($156,925)
- 4 Open-market sale President, Global Head of R&D sold 1,169 shares at $265.39 ($310,236)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Principal Accounting Officer sold 169 shares at an average $257.20 ($43,467)
- 4 Open-market sale President, Global Head of R&D sold 756 shares at $261.00 ($197,318)
- 4 Open-market sale Chief Financial Officer sold 631 shares at $257.74 ($162,637)
Page 3 of 64 · 1,277 filings